Abstract:Background: Patients with Alzheimer's disease (AD) often exhibit characteristic clinical manifestations, particularly neuropsychiatric symptoms. Previous studies have shown that white matter hyperintensity (WMH) is strongly associated with AD progression, as well as neuropsychiatric symptoms. The purpose of this study was to investigate the clinical and neuropsychological characteristics of AD patients with WMH. Methods: This retrospective study involved 104 18-fluorodeoxyglucose-positron emission computed tomography (18FDG-PET-CT)-defined AD patients treated at Tianjin Huanhu Hospital from January 2010 to December 2022. Cranial magnetic resonance imaging (MRI) provided semi-quantitative data on brain structure and WMH. Collect and analyze patient clinical data. Neuropsychological assessments were used to evaluate cognitive function and psychobehavioral traits. Results: Among the 104 patients, 66 were in the WMH group (63.5%) and 38 in the non-white matter hyperintensity (non-WMH) group (36.5%). There were no significant differences in gender, age, age of onset, education, BMI, smoking, drinking, diabetes, coronary heart disease, dementia family history, fasting blood glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) between the two groups. The WMH group showed higher rates of hypertension, homocysteine (Hcy) levels, NPI, and CDR scores as compared to the non-WMH group (p < 0.05). MMSE and MoCA scores were significantly lower in the WMH group (p < 0.05). In the MMSE subitem analysis, patients in the WMH group showed a decrease in attention, recall, and language scores. In the MOCA subitem analysis, WMH patients had lower scores in executive function, naming, attention, language, abstraction, and orientation (p < 0.05). Furthermore, subgroup analysis of NPI showed a higher incidence of delusions, depression, and apathy in the WMH group (p < 0.05). According to the hierarchical analysis of mild, moderate and severe dementia groups, the hypertension, leukoencephalopathy, Hcy level, Fazekas total score, PWMH and DWMH scores in the severe dementia group were significantly higher than those in the mild and moderate dementia groups (p < 0.05). As the disease progresses, more and more patients show increased white matter hyperintensity. Conclusion: White matter lesions are closely correlated with cognitive decline and psychobehavioral symptoms in AD patients, and may be used as an indicator of disease progression. Priority should be given to early screening and prevention of WMH-related risk factors.

Regional Quantification of White Matter Hyperintensity in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

Impact of Different White Matter Hyperintensities Patterns on Cognition: A Cross-Sectional and Longitudinal Study.

Characterization of Local White Matter Microstructural Alterations in Alzheimer’s Disease: A Reproducible Study

DIFFERENTIAL GREY AND WHITE MATTER MICROSTRUCTURAL ABNORMALITIES IN EARLY AND LATE-ONSET ALZHEIMER’S DISEASE AND MILD COGNITIVE IMPAIRMENT

Quantitative Measurement of White Matter Hyperintensities Volume in Different Types of Dementia Based on Computer-Aided Detection of Lesions

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

The Correlation Between White Matter Hyperintensity Burden and Regional Brain Volumetry in Patients With Alzheimer's Disease

Alteration of Regional Homogeneity and White Matter Hyperintensities in Amnestic Mild Cognitive Impairment Subtypes Are Related to Cognition and CSF Biomarkers

Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD

Regional White Matter Hyperintensities Relate to Specific Cognitive Abilities in Older Adults Without Dementia

Correspondence between white matter hyperintensities and regional grey matter volumes in Alzheimer's disease

Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function

White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts

Automated Volumetric Measurement of Brain Structures and White Matter Lesions in Alzheimer's Disease and Mild Cognitive Impairment

Association of white matter hyperintensities with cognitive decline and neurodegeneration

THE CUMULATIVE SPATIAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES AND ITS CRITICAL STAGE THAT AFFECTS COGNITION AND THE BRAIN IN NON-DEMENTED ELDERLY

Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study

Microstructural White Matter Abnormalities Independent of White Matter Lesion Burden in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease among Han Chinese Elderly.

The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China

Regional White Matter Decreases in Alzheimer's Disease Using Optimized Voxel-Based Morphometry

Volumetric quantitation and qualitation of white matter lesions in evaluation of cognitive impairment